First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study

Yi‐Long Wu, Caicun Zhou, Chong Kin Liam, Gang Wu, Xuan Liu, Zhaoyang Zhong, Shun Lü, Ying Cheng, Baohui Han, Lin Chen, Cheng Huang, Shanshan Qin, Yixiang Zhu, Hui Pan, Houjie Liang, Elizabeth Li, Guangliang Jiang, Soon Hin How, Mitchel Fernando, Y. Zhang, Fan Xia, Yanchen Zuo

Annals of Oncology, 2015